DUBLIN--(BUSINESS WIRE)--Jul 13, 2020--

The global neurosurgery devices market grew at a CAGR of around 12% during 2014-2019. Looking forward, the publisher expects the market to exhibit strong growth during the next five years.

Neurosurgery devices refer to various tools and instruments that are used for conducting surgeries and treating various pathologies in the central and peripheral nervous systems. They are primarily used for diagnosing, preventing and treating conditions such as Parkinson's, Alzheimer's, depression, epilepsy and traumatic brain and spinal cord injury. Some of the commonly used devices include neurostimulation devices, neurosurgical navigation devices and cerebrospinal fluid (CSF) management devices, such as curettes, dissectors, elevators and rongeurs. These tools aid in conducting microsurgeries, discectomies, elevating the periosteum below temporalis muscle and adjusting the skull bone during surgeries.

The increasing prevalence of various neurological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to neurological and other medical ailments, is also providing a boost to the market growth. There is also an increasing health consciousness and awareness among the masses regarding the availability of effective treatment alternatives for neurological disorders, which is contributing to the market growth. Consequently, there is a growing preference for neuroendoscopy surgeries over traditional brain surgeries.

For instance, various neurostimulation devices are used to send electrical impulses to the targeted sacral nerves and perform deep brain stimulation. Additionally, various technological advancements, including the development of innovative minimally invasive (MI) equipment, such as flow diversion, liquid embolic and clot retrieval devices, neuroendovascular stents and balloon catheters, are acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are projected to drive the market further.

Companies Mentioned

  • Abbott Laboratories
  • Ackermann Instrumente GmbH
  • Adeor Medical AG
  • B. Braun Melsungen
  • Biotronik
  • Boston Scientific Corporation
  • DePuy Synthes Inc.
  • Integra Lifesciences
  • Johnson & Johnson Services Inc.
  • Medtronic Inc.
  • Nevro Corporation
  • Nihon Kohden Corporation
  • Penumbra Inc.
  • Stryker Corporation

Key Questions Answered in this Report:

  • How has the global neurosurgery devices market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global neurosurgery market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.3.1 Primary Sources

2.3.2 Secondary Sources

2.4 Market Estimation

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Neurosurgery Devices Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Forecast

6 Market Breakup by Product Type

6.1 Neurostimulation Devices

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Neurointerventional Devices

6.2.1 Market Trends

6.2.2 Market Forecast

6.3 Neurosurgical Navigation Systems

6.3.1 Market Trends

6.3.2 Market Forecast

6.4 Cerebral Spinal Fluid (CSF) Management Devices

6.4.1 Market Trends

6.4.2 Market Forecast

6.5 Others

6.5.1 Market Trends

6.5.2 Market Forecast

7 Market Breakup by User Type

7.1 Spinal Cord Stimulation

7.1.1 Market Trends

7.1.2 Market Trends Chronic Pain Failed Back Surgery Syndrome Ischemia

7.1.3 Market Forecast

7.2 Deep Brain Stimulation

7.2.1 Market Trends

7.2.2 Market Trends Parkinson's Disease Tremor Depression Others

7.2.2 Market Forecast

7.3 Neuroendoscopy

7.3.1 Market Trends

7.3.2 Market Trends Transnasal Neuroendoscopy Intraventricular Neuroendoscopy Transcranial Neuroendoscopy

7.3.3 Market Forecast

8 Market Breakup by End-User

8.1 Hospitals

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 Ambulatory Surgical Centers

8.2.1 Market Trends

8.2.2 Market Forecast

8.3 Others

8.3.1 Market Trends

8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America

9.2 Asia Pacific

9.3 Europe

9.4 Latin America

9.5 Middle East and Africa

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Indicators

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/v2k1gf

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 07/13/2020 06:34 AM/DISC: 07/13/2020 06:34 AM

Copyright Business Wire 2020.